Publications by authors named "Svetlana Kopishinskaia"
Article Synopsis
- Several neurological issues can persist in patients who have recovered from COVID-19, and this study focused on their outcomes at the 6-month mark.
- The research involved over 1,000 patients and found that approximately 52% showed stable or improved functional status, while 46% experienced worse outcomes, with factors like age and hospitalizations influencing these results.
- Among the neurological symptoms that persisted, fatigue and memory or concentration problems were the most common, highlighting the need for awareness of long-term effects in COVID-19 survivors.
Somatic multicomorbidity and disability in patients with psychiatric disorders in comparison to the general population: a quasi-epidemiological investigation in 54,826 subjects from 40 countries (COMET-G study).
CNS Spectr
April 2024
Background: The prevalence of medical illnesses is high among patients with psychiatric disorders. The current study aimed to investigate multi-comorbidity in patients with psychiatric disorders in comparison to the general population. Secondary aims were to investigate factors associated with metabolic syndrome and treatment appropriateness of mental disorders.
View Article and Find Full Text PDFBackground: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a severe, debilitating chronic disease characterized by marked tiredness and fatigue, cognitive dysfunction, sleep disturbances, pain, and autonomic, immunological, and metabolic dysfunctions, in which all symptoms are usually exacerbated by physical and/or psychological stress.
Subjects And Methods: We report a case of ME/CFS with severe myalgia and severe locomotor disorders in a 25-year-old female after Gam-COVID-Vac vaccine (Sputnik V) ten days before the manifestation of the symptoms.
Results: This is the first report of such a complication from the Gam-COVID-Vac vaccine.
Article Synopsis
- A large international study involving 55,589 participants from 40 countries was conducted to assess the impact of COVID-19 on mental health, revealing that 17.80% of participants experienced probable depression and 16.71% reported distress.
- The research indicated that individuals with a history of mental disorders showed significantly higher rates of depression, with the highest risk linked to conditions like Bipolar disorder and self-harm, and found that belief in conspiracy theories was prevalent among participants.
- The study developed a model demonstrating the connection between anxiety, distress, and the progression to probable depression and suicidality, suggesting that addressing modifiable factors could be beneficial in improving mental health outcomes.
Background: Olfactory dysfunction is a typical symptom of COVID-19 infection. While COVID-associated anosmia is well-described, knowledge of parosmia (olfactory distortions) and phanthosmia (olfactory hallucinations) is relatively lacking. We undertook a clinical study of the parosmia/phanthosmia phenotype, aiming to support improved prediction and management of these symptoms.
View Article and Find Full Text PDFCatatonia is a rare neuropsychiatric syndrome that can accompany various medical conditions, including schizophrenia, autoimmune encephalitis, and infectious diseases. We present two cases of catatonia in males aged 12 and 17 years from Central Asia who tested positive for SARS-Cov-2 antibodies. Detailed medical assessments declined other potential precipitating factors, including schizophrenia or anti-NMDA receptor autoimmune encephalitis.
View Article and Find Full Text PDF